- Report
- February 2024
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2023
- 129 Pages
Global
€4826EUR$5,000USD£4,140GBP
Eulexin (flutamide) is a prostate cancer drug used to treat advanced stages of the disease. It is an anti-androgen, meaning it works by blocking the action of male hormones in the body. It is usually used in combination with other drugs, such as leuprolide or goserelin, to reduce the risk of cancer progression. Eulexin is taken orally, usually twice a day. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
The Eulexin market is highly competitive, with a number of companies offering similar products. Companies in the market include AstraZeneca, Pfizer, Merck, and Novartis. These companies are all major players in the pharmaceutical industry, and have a long history of developing and marketing drugs for the treatment of prostate cancer. Show Less Read more